Measuring and improving the quality of transurethral resection for bladder tumour (TURBT)

BJU International

Volumn 109, Issue 11, 2012, Pages 1579-1582

  Mostafid, Hugh ^a   Brausi, Maurizio ^b  

^a NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

^b Nuovo Ospedale S Agostino   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIPOLAR ELECTROCAUTERY; BLADDER BIOPSY; BLADDER CANCER; BLADDER CARCINOMA IN SITU; BLADDER DISEASE; BLADDER DYSPLASIA; BLADDER PAPILLOMA; BLADDER PERFORATION; BLADDER SURGERY; BLADDER TUMOR; BLOOD TRANSFUSION; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CAUTERIZATION; CLINICAL COMPETENCE; CYSTOSCOPY; DETRUSOR MUSCLE; DIAGNOSTIC ACCURACY; FOLLOW UP; HEALTH CARE QUALITY; HEMATURIA; HISTOPATHOLOGY; HUMAN; MEDICAL AUDIT; NOTE; OUTCOME ASSESSMENT; PATIENT SELECTION; PEROPERATIVE COMPLICATION; PHOTODYNAMICS; POSTOPERATIVE CARE; PRIORITY JOURNAL; RECURRENCE RISK; REOPERATION; SENSITIVITY ANALYSIS; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURGICAL TRAINING; TRANSURETHRAL RESECTION FOR BLADDER TUMOR; UROLOGIST; WHITE LIGHT CYSTOSCOPY;

CYSTECTOMY; CYSTOSCOPY; HUMANS; PATIENT SELECTION; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84860609042     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10638.x     Document Type: Note

References (24)

1. Jones HC, Swinney J,. The treatment of tumours of the bladder by transurethral resection. Br J Urol 1962; 34: 215-20
2. Lee F, Patel HR, Emberton M,. The 'top 10' urological procedures: a study of hospital episodes statistics 1998-99. BJU Int 2002; 90: 1-6
3. Emberton M, Neal DE, Black N, et al,. The National Prostatectomy Audit: the clinical management of patients during hospital admission. Br J Urol 1995; 75: 301-16
4. Nieder AM, Meinbach DS, Kim SS, Soloway MS,. Transurethral bladder tumor resection: intraoperative and postoperative complications in a residency setting. J Urol 2005; 174: 2307-9 (Pubitemid 41611811)
5. Brausi M, Sylvester R, van der Meijden A, Kurth KH,. Does the surgeon have an impact in the outcome of patients with Ta-T1 TCC of the bladder? Results of an EORTC quality control study on TURBT. Eur Urol 2001; 39 (Suppl. 5): 119 (abstract 466)
6. Jichlinski P, Leisinger HJ,. Fluorescence cystoscopy in the management of bladder cancer: a help for the urologist! Urol Int 2005; 74: 97-101 (Pubitemid 40529123)
7. Jocham D, Stepp H, Waidelich R,. Photodynamic diagnosis in urology: state-of-the-art. Eur Urol 2008; 53: 1138-48
8. Witjes JA, Redorta JP, Jacqmin D, et al,. Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations. Eur Urol 2010; 57: 607-14
9. Herr HW, Donat SM,. Quality control in transurethral resection of bladder tumours. BJU Int 2008; 102: 1242-6
10. Mariappan P, Zachou A, Grigor K,. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts riask of early recurrence, and is dependent on operator experience. Eur Urol 2010; 57: 843-9
11. Herr HW,. The Value of a second transurethral resection in evaluating patients with bladder tumours. J Urol 1999; 162: 74-6 (Pubitemid 29420883)
12. Dalbagni G, Vora K, Kaag M, et al,. Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer. Eur Urol 2009; 56: 903-10
13. Herr HW, Donat SM,. A re-staging transurethral resection predicts early progression of superficial bladder cancer. BJU Int 2006; 97: 1194-8 (Pubitemid 43907320)
14. Brausi M, Collette L, Kurth K, et al,. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 2002; 41: 523-31
15. Bryan RT, Collins SI, Daykin MC, et al,. Mechanisms of recurrence of Ta/T1 bladder cancer. Ann R Coll Surg Engl 2010; 92: 519-24
16. Brausi M, Gavioli M, Peracchia G, et al,. Dedicated teaching programs can improve the quality of TUR of non-muscle-invasive bladder tumours (NMIBT):experience of a single institution. Eur Urol Suppl 2008; 7: 180 (abstract 437)
17. Vickers AJ, Savage F, Bianco F, et al,. Cancer control and functional outcomes after radical prostatectomy as markers of surigcal quality: analysis of heterogeneity between surgeons at a single cancer centre. Eur Urol 2011; 59: 317-22
18. van der Meijden A, Oosterlinck W, Brausi M, Kurth KH, Sylvester R, de Balincourt C,. Significance of bladder biopsies in Ta,T1 bladder tumors: a report from the EORTC Genito-Urinary Tract Cancer Cooperative Group. EORTC-GU Group Superficial Bladder Committee. Eur Urol 1999; 35: 267-71 (Pubitemid 29154829)
19. May F, Treiber U, Hartung R, Schwaibold H,. Significance of random bladder biopsies in superficial bladder cancer. Eur Urol 2003; 44: 47-50 (Pubitemid 36741374)
20. Sylvester RJ, van der Meijden AP, Oosterlinck W, et al,. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006; 49: 466-7
21. Kausch I, Sommerauer M, Montorsi F, et al,. Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies. Eur Urol 2010; 57: 595-606
22. Gupta NP, Saini AK, Dogra PN, Seth A, Kumar R,. Bipolar energy for transurethral resection of bladder tumours at low-power settings: initial experience. BJU Int 2011; 108: 553-6
23. Xylinas E, Ploussard G, Durand X, et al,. Evaluation of combined oncological and functional outcomes after radical prostatectomy: trifecta rate of achieving continence, potency and cancer control-a literature review. Urology 2010; 76: 1194-8
24. Barocas DA, Mitchell R, Chang SS, Cookson MS,. Impact of surgeon and hospital volume on outcomes of radical prostatectomy. Urol Oncol 2010; 28: 243-50